The foregoing descriptions of the Notes, the Pre-Funded Warrants, the Note Purchase Agreement, the Registration Rights Agreement, the Supply Agreement and the Master Transaction Agreement do not purport to be complete and are qualified in their entirety by reference to the complete text of the Form of Notes, the Form of Pre-Funded Warrants, the Note Purchase Agreement, the Registration Rights Agreement, the Supply Agreement, and the Master Transaction Agreement, which are filed herewith as Exhibits 1 through 6 to this Schedule 13D and are incorporated herein by reference.
The Reporting Persons acquired the securities covered by this Schedule 13D in connection with the transactions contemplated by the Note Purchase Agreement, the Supply Agreement and the Master Transaction Agreement. The Reporting Persons intend to engage in discussions with the Issuer’s management and Board regarding the Issuer’s operations, strategic direction, and potential additional transactions among the Reporting Persons and the Issuer. As contemplated by the Master Transaction Agreement, the Reporting Persons’ discussions with the Issuer will include, without limitation, the completion of the Reporting Persons’ designation of two designees to serve on the Issuer’s Board and the negotiation, on terms and conditions reasonably acceptable to the parties, of an extension of the Supply Agreement. While there can be no assurance any such extension will be consummated, such negotiation may result in an extension, amendment, restatement, or other modification of the Supply Agreement, and may result in the issuance of additional Notes and/or other securities of the Issuer to the Reporting Persons. In addition, depending upon overall market conditions, changes in the Issuer’s operations, business strategy or prospects, other investment opportunities available to the Reporting Persons and the availability of securities of the Issuer at prices that would make the purchase or sale of any such securities desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer in the open market, private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.
The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the shares of Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may consider, explore and/or develop plans regarding the Issuer in addition to the matters discussed above, and may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in other communications with the Issuer’s management and Board, engaging in discussions with other securityholders of the Issuer and others about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer concerning changes to the capital allocation strategy, capitalization, ownership structure, strategic transactions, including business combinations, a sale of the Issuer as a whole or in parts or acquisitions or investments by the Issuer, increased representation or designation rights of the Reporting Persons on the Board, Board structure (including Board composition), operations of the Issuer, purchasing additional securities of the Issuer, selling some or all of their Issuer securities, engaging in short selling of or any hedging or similar transaction with respect to securities of the Issuer, or taking any other actions with respect to their investment in the Issuer permitted by law, including any or all of the actions set forth in paragraphs (a)-(j) of Item 4 of Schedule 13D. The Reporting Persons may at any time reconsider and change their plans or proposals relating to the foregoing.
Item 5. | Interest in Securities of the Issuer. |
(a)–(b) Each of the Reporting Persons may be deemed to beneficially own, and may be deemed to have shared power to direct the vote and shared power to dispose or to direct the disposition of, in the aggregate, 18,380,242 shares of Common Stock, representing approximately 18.7% of the issued and outstanding shares of Common Stock, based on (i) 79,750,000 shares of Common Stock outstanding as of February 2, 2022, as represented by the Issuer in the Note Purchase Agreement, plus (ii) 9,190,121 shares of Common Stock issuable to ProFrac Holdings upon conversion of $10,000,000 in aggregate principal amount of the Initial Notes, plus (iii) 9,190,121 shares of Common Stock issuable to ProFrac Holdings upon conversion of $10,000,000 in aggregate principal amount of the Additional Notes in each case based upon conversion of the Notes at the Conversion Price, and not including the conversion of any accrued but unpaid interest on any Notes.
Each of Farris Wilks and THRC Holdings owns 50% of the membership interests in ProFrac Holdings. In addition, Farris Wilks and Dan Wilks are the sole managers of ProFrac Holdings. As a result, each of Farris Wilks, Dan Wilks and THRC Holdings therefore may be deemed to have shared voting and investment power over, and to share beneficial ownership of, the shares of Common Stock beneficially owned by ProFrac Holdings. THRC Management, as General Partner of THRC Holdings, has exclusive voting and investment power over the shares of Common Stock beneficially owned by THRC Holdings, and therefore may be deemed to share beneficial ownership of such shares. Dan Wilks, as sole Manager of THRC Management, together with his spouse, Staci Wilks, who share the same household, may be deemed to exercise voting and investment power over the shares of Common Stock beneficially owned by THRC Holdings, and therefore may be deemed to share beneficial ownership of such shares.
(c) The information set forth in Item 3 and Item 4 of this Schedule 13D is incorporated by reference into this Item 5(c).
(d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock.
(e) Not applicable.
Page 10